Bictegravir-Based Treatment Wins for HIV/HBV Co-Infections - Medpage Today

Head-to-head comparison in ALLIANCE trial favors use over dolutegravir-based combination

MONTREAL -- For individuals infected by both HIV and hepatitis B virus (HBV), the choice of which virus-suppressing therapy to use can make a difference in outcomes, according to 48-week results of t… [+3592 chars]

full article...